Pfizer (PFE) Misses Q4 EPS by 6c, Raises FY21 EPS Guidance

Pfizer (NYSE: PFE) reported Q4 EPS of $0.42, $0.06 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.43 billion.

GUIDANCE:

Pfizer sees FY2021 EPS of $3.10-$3.20, versus the consensus of $3.19. Pfizer sees FY2021 revenue of $59.4-61.4 billion, versus the consensus of $56.72 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
• Build-A-Bear Workshop (BBW) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY Guidance